We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Imperial College London.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00446121
First Posted: March 12, 2007
Last Update Posted: March 12, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Imperial College London
  Purpose
The main purpose of the study is to evaluate the effect of mannitol on the cilia's beat frequency (ciliary beat frequency) in COPD patients.

Condition
Chronic Obstructive Pulmonary Disease

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: The Effect of Inhaled Mannitol on Ciliary Beat Frequency in COPD Patients

Resource links provided by NLM:


Further study details as provided by Imperial College London:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   38 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00446121


Contacts
Contact: Sergei Kharitonov, MD PhD +44 02073518051 s.kharitonov@imperial.ac.uk
Contact: Lars Pedersen, MD +44 02073518051 l.pedersen@imperial.ac.uk

Locations
United Kingdom
Airway Disease Section, Asthma Lab, Imperial College London, Royal Brompton Hospital Recruiting
London, United Kingdom, SW3 6LY
Contact: Sergei Kharitonov, MD PhD    +44 02073518051    s.kharitonov@imperial.ac.uk   
Contact: Lars Pedersen, MD    +44 02073518051    l.pedersen@imperial.ac.uk   
Principal Investigator: Sergei Kharitonov, MD PhD         
Sub-Investigator: Lars Pedersen, MD         
Sub-Investigator: Peter J Barnes, MA DM DSc FRCP         
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Sergei Kharitonov, MD PhD Imperial College London
  More Information

ClinicalTrials.gov Identifier: NCT00446121     History of Changes
Other Study ID Numbers: 06/Q0410/55
First Submitted: March 9, 2007
First Posted: March 12, 2007
Last Update Posted: March 12, 2007
Last Verified: March 2007

Keywords provided by Imperial College London:
COPD

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases
Mannitol
Diuretics, Osmotic
Diuretics
Natriuretic Agents
Physiological Effects of Drugs